Evidence map›Paper›PMID 22305561›Full record

ReviewCell stem cell2012

The potential of stem cells as an in vitro source of red blood cells for transfusion.

Anna Rita Migliaccio, Carolyn Whitsett, Thalia Papayannopoulou, Michel Sadelain

Abstract readReview
In one paragraph

Review in Cell stem cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Research progress on optimization ofFrontiers in bioengineering and biotechnology · 2024
    Review
  3. Review
  4. Article
  5. BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy.Journal of biological research (Thessalonike, Greece) · 2018
    Article
  15. Article
  16. Article
  17. The virtual cell based assay: Current status and future perspectives.Toxicology in vitro : an international journal published in association with BIBRA · 2017
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna Rita MigliaccioTisch Cancer Center, Mount Sinai School of Medicine, New York, NY 10029, USA. annarita.migliaccio@mssm.edu
Carolyn Whitsett
Thalia Papayannopoulou
Michel Sadelain

Funding

VECTOR CONSTRUCTIONS FOR GENE THERAPY OF SICKLE CELL DISEASEP01HL053750 · NHLBI · UNIVERSITY OF WASHINGTON · PI RUSSELL, DAVID W · 1994 to 2014
$30.4M
The human glucocorticoid receptor and normal and pathological terminal erythroidR01HL116329 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MIGLIACCIO, ANNA RITA F · 2012 to 2015
$1.7M
NHLBI NIH HHS P01 HL053750NHLBI NIH HHS R01 HL116329
6 · The paper itself

Abstract

Recent advances have increased excitement about the potential for therapeutic production of red blood cells (RBCs) in vitro. However, generation of RBCs in the large numbers required for transfusion remains a significant challenge. In this article, we summarize recent progress in producing RBCs from various cell sources, and discuss the hurdles that remain for translation into the clinical arena.

Indexed as

Cell Culture TechniquesErythrocyte TransfusionAnimalsCell ProliferationClinical Trials as TopicErythrocytesHumansStem Cells

Identifiers

PMID22305561
PMCPMC3676433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.